Educational information, not medical advice — ask your doctor or midwife.
Track Photobiomodulation Therapy with reminders and see your options for Trigeminal Neuralgia in the app.
Photobiomodulation therapy (PBM) uses carefully chosen wavelengths of red and near-infrared light — usually between 630 and 1100 nanometers — to penetrate skin and soft tissue without generating damaging heat. Unlike UV light, these wavelengths do not burn or damage cells; instead they are absorbed by light-sensitive proteins inside your cells and trigger a cascade of beneficial biological responses. PBM is delivered using lasers or LED arrays and is used in clinics, sports medicine, dermatology offices, and increasingly at home through consumer-grade devices.
The primary target inside your cells is a protein called cytochrome c oxidase, a key enzyme in the mitochondria — your cells' energy factories. When red or near-infrared light hits this protein, it boosts the production of ATP (cellular energy currency), reduces oxidative stress, and prompts cells to release signaling molecules that calm inflammation and kickstart repair. In simpler terms, light gives your cells an energy boost and tells them to heal more efficiently. This process also increases local blood flow and stimulates collagen production in skin and connective tissue.
Clinical-grade devices use precisely calibrated lasers or high-density LED arrays and are operated by trained practitioners. Home-use LED panels range from small targeted pads to large full-body panels and are generally safe and effective for maintenance and skin health. Laser caps and helmets deliver light to the scalp for hair loss treatment. Wearable pads and wraps target specific joints or muscle groups. For serious medical conditions, clinical devices consistently outperform consumer devices due to higher irradiance and precision.
PBM was discovered almost accidentally in 1967 when Hungarian physician Endre Mester found that a low-powered ruby laser stimulated hair regrowth and wound healing in mice. Over the following decades, the therapy expanded into pain medicine, physical therapy, dentistry, and dermatology. The term 'photobiomodulation' was formally adopted by the scientific community in the 2010s to distinguish therapeutic light from harmful or surgical laser applications, and the field has grown substantially with hundreds of controlled clinical trials published to date.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Everyday descriptions of the problems this remedy is recommended for.
Each grade below is for that condition specifically, not for Photobiomodulation Therapy in general.
The 4 options with the best evidence for Trigeminal Neuralgia, each with its grade and who should avoid it. One email.
Occasional evidence updates after that — unsubscribe any time.